BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299 [PMID: 36185629 DOI: 10.3748/wjg.v28.i36.5280]
URL: https://www.wjgnet.com/1948-5182/full/v28/i36/5280.htm
Number Citing Articles
1
Tejinder Pal Singh, Saurabh Kadyan, Harisha Devi, Gwoncheol Park, Ravinder Nagpal. Gut microbiome as a therapeutic target for liver diseasesLife Sciences 2023; 322 doi: 10.1016/j.lfs.2023.121685
2
Naoto Fujiwara, Genki Kimura, Hayato Nakagawa. Emerging Roles of Spatial Transcriptomics in Liver ResearchSeminars in Liver Disease 2024; 44(02) doi: 10.1055/a-2299-7880
3
Dennis R. Warner, Jeffrey B. Warner, Josiah E. Hardesty, Yasmeen Abdelfadil, Chirag Soni, Philip Bauer, Claudio Maldonado, Craig J. McClain, Irina A. Kirpich. Hepatocyte-Specific Transcriptional Responses to Liver-Targeted Delivery of a Soluble Epoxide Hydrolase Inhibitor in a Mouse Model of Alcohol-Associated Liver DiseaseBiology 2025; 14(9) doi: 10.3390/biology14091267
4
Tian Liu, Chun Li, Guofang Zhang, Libo Liu, Wenjing Li, Liying Wang, Peng Du. Mechanism of action of postbiotics intervention in alcoholic liver injury and future research directionsFood Nutrition 2026; 2(1) doi: 10.1016/j.fnutr.2026.100057
5
S. V. Tsaregorodtsev, I. V. Maev, A. V. Zaborovskiy, N. A. Pyataev, L. A. Tararina, A. G. Mulyar, M. Yu. Savelyev, A. V. Vychkin, N. V. Kheladze, I. M. Dadayeva. Nanosomal Forms of Hepatoprotectors in Acute Liver Injury: A ReviewPharmaceutical Chemistry Journal 2026; 59(10) doi: 10.1007/s11094-026-03495-4
6
Jin Seok Hwang, Trang Huyen Lai, Deok Ryong Kim. Targeting Lipophagy in Liver Diseases: Impact on Oxidative Stress and SteatohepatitisAntioxidants 2025; 14(8) doi: 10.3390/antiox14080908
7
Kulzhan Berikkhanova, Isah Inuwa, Erlan Taigulov, Saken Kozhakhmetov, Nurzhan Bikhanov, Ardak Omarbekov, Gulsara Berikkhanova, Yessenhan Sultan, Abdulrahman Garba Jibo, Saniya Abdrakhmanova, Zhannat Zhakiyanova, Gulyash Tanysheva, Zhaxybay Zhumadilov. Biomimetic Targeted Drug Delivery for Liver Failure in Abdominal Sepsis: Focus on Autologous Erythrocyte GhostsInternational Journal of Molecular Sciences 2026; 27(11) doi: 10.3390/ijms27114978
8
Nura Adam Mohamed, Farah Atifi, Zineb Ourradi, Sergio Crovella, Moutaz Derbala, Hadi M. Yassine, Ejaife O. Agbani, Yahye Merhi, Younes Zaid, Haissam Abou-Saleh. Nanoparticle approaches for hepatitis therapy and clinical translationDiscover Nano 2026; 21(1) doi: 10.1186/s11671-026-04450-8
9
Shaira Gail Santos, Khaja Shameem Mohammed Abdul, Nicole H Purcell. Protein phosphatases in metabolic dysfunction-associated steatotic liver disease: emerging mechanisms and therapeutic strategiesCurrent Opinion in Physiology 2025; 46 doi: 10.1016/j.cophys.2025.100860
10
Janitha M. Unagolla, Subarna Das, Riley Flanagan, Marin Oehler, Jyothi U. Menon. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectivesInternational Journal of Pharmaceutics 2024; 660 doi: 10.1016/j.ijpharm.2024.124381
11
Drug Delivery2025;  doi: 10.1016/B978-0-443-26787-1.00013-8
12
Gaurav Mittal, Prashanth A, Arkadeep Dhali, Roshan Prasad, Yogesh S, Khulud Mahmood Nurani, Mihnea-Alexandru Găman. Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systemsWorld Journal of Gastroenterology 2025; 31(18): 105836 doi: 10.3748/wjg.v31.i18.105836
13
Xuehan Li, Haiyang Zhang, Xiangzhao Mao. Food-borne Delivery Systems of Functional Substances for Precision NutritionAdvances in Food and Nutrition Research 2024; 112 doi: 10.1016/bs.afnr.2024.06.010
14
Ziyi Zhang, Ruxin Chang, Qing Yue, Bin Liu, Zekun Li, Yu Yuan, Shuang Liang, Yuan Li. Food-borne Delivery Systems of Functional Substances for Precision NutritionAdvances in Food and Nutrition Research 2024; 112 doi: 10.1016/bs.afnr.2024.05.008
15
Janitha M. Unagolla, Riley Flanagan, Kalindu Perera, Youbin Kim, Curtis Soloff, Emily Kaye, Angela Slitt, Jyothi U. Menon. A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver diseaseBiomaterials 2026; 325 doi: 10.1016/j.biomaterials.2025.123623
16
Yedi Herdiana, Jutti Levita, Supat Jiranusornkul. Chitosan-Based Nanoparticles Targeted Delivery System: In Treatment Approach for DyslipidemiaInternational Journal of Nanomedicine 2025;  doi: 10.2147/IJN.S517492
17
Thiago Oliveira, Gleisy Gonçalves. State-of-the-art Evaluation and Management of Hepatobiliary Diseases [Working Title]2026;  doi: 10.5772/intechopen.1012571
18
Srikar Grandhi, Moawia Al-Tabakha, Prameela Rani Avula, Kuldeep Singh. Enhancement of Liver Targetability through Statistical Optimization and Surface Modification of Biodegradable Nanocapsules Loaded with LamivudineAdvances in Pharmacological and Pharmaceutical Sciences 2023; 2023 doi: 10.1155/2023/8902963
19
Zi Hong Mok. The effect of particle size on drug bioavailability in various parts of the bodyPharmaceutical Science Advances 2024; 2 doi: 10.1016/j.pscia.2023.100031
20
Qian-Lan Wu, Jing Li, Tian-Le Mao, Xin Guo, Zhi-Jing Ni, Kiran Thakur, Yi-Long Ma, Zhao-Jun Wei. In vitro bioaccessibility and alcoholic injury-alleviation effect of Lycium barbarum leaf phenolicsJournal of Future Foods 2026;  doi: 10.1016/j.jfutfo.2026.01.012
21
Ankit Jain, Ashwini Kumar Mishra, Pooja Hurkat, Satish Shilpi, Nishi Mody, Sanjay Kumar Jain. Navigating liver cancer: Precision targeting for enhanced treatment outcomesDrug Delivery and Translational Research 2025; 15(6) doi: 10.1007/s13346-024-01780-x
22
Shivam Verma, Priyanka Maurya, Shailendra K. Saraf, Neelam Datt. Ameliorative effect of dextrose coated rebamipide liposomes for liver cirrhosis: in vitro and in vivo characterizationFuture Journal of Pharmaceutical Sciences 2025; 11(1) doi: 10.1186/s43094-025-00826-2
23
Ming-Fo Hsu, Shinichiro Koike, Chang-Shan Chen, Sonia M. Najjar, Tzu-Ching Meng, Fawaz G. Haj. Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver diseaseBiomedicine & Pharmacotherapy 2024; 175 doi: 10.1016/j.biopha.2024.116590
24
Mona M. AbouSamra. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applicationsJournal of Liposome Research 2024; 34(4) doi: 10.1080/08982104.2024.2377085
25
Vikas Gupta, Tejasav S. Sehrawat, Massimo Pinzani, Mario Strazzabosco. Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational OpportunitiesGastroenterology 2025; 168(4) doi: 10.1053/j.gastro.2024.07.044